QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)

$6.86 -0.16 (-2.2792%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) News Sources

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

30-03-2026

yahoo.com

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

01-04-2026

yahoo.com

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

02-04-2026

yahoo.com

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

22-04-2026

yahoo.com

Quantum BioPharma Provides Corporate Update

27-04-2026

yahoo.com

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

07-05-2026

yahoo.com

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

18-05-2026

yahoo.com

Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM)

18-05-2026

advfn.com

Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH

19-05-2026

yahoo.com

Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study

19-05-2026

yahoo.com

QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) Sentiment Trend

0 25 50 75 100 70 68 54 78 83 55 76 73 87 66 30-03-2026 01-04-2026 02-04-2026 22-04-2026 27-04-2026 07-05-2026 18-05-2026 19-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) FAQs

toggle

What is the current price of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?

The current price of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is $6.86.


toggle

QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) absolute price change since previous trading day?

The absolute price change of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) since the previous trading day is $-0.16.


toggle

QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) percentage price change since previous trading day?

The percentage price change of QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) since the previous trading day is -2.2792%.


toggle

What is the most recent average sentiment score for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?

The most recent average sentiment score for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is 71 out of 100.


toggle

What is the most recent average sentiment for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)?

The most recent sentiment for QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ) is .


SEC-8K** Filing Available For QUANTUM BIOPHARMA-B SUB VOT (QNTM:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.